Post by tw12 on Jan 2, 2018 20:26:41 GMT -5
I know, I know. I continue to assault you guys with flagrant optimism. But since it’s the happy onset of a new swing around the sun, permit me a quick note of fortune telling. Can't resist. Must be the wolf moon. In 2018, MannKind will:
* Sign at least four major marketing agreements for Afrezza. At least two will involve ultra-sensible, region-wide deals. In order of likelihood: the Mid-East, Central America and the Caribbean, and Europe. And at least three will be with specific countries. Brazil is already on board, and I suspect India is an absolutely irresistible target for Mike and company, slightly easier to ink an attractive deal than with China (key word “attractive”). I’ll bet Indonesia as a dark horse - and Canada is such an easy target too.
* Sign a major deal with BP for marketing a Technosphere vasodilator.
* Sign a medical marjiuana deal. This seems the hardest arena to predict, but I well suspect that MannKind and One Drop will ink a tri-partite deal with a major company, likely Apple or Google. So much potential there and they have the cash to make it happen quickly.
* Surprise the hell out of us with a deal no one has predicted.
So this year Mike will announce at least a half-dozen major deals. And of course MNKD will be 2018’s highest gaining NASDAQ stock, beginning today at 2.32 and ending on December 31 at 146. Up 6193%. Nice!
But I'll bet the best year-end smiles from Mike C. and the hundreds of folks who have worked so hard on Afrezza and continue to do so, won’t be about the stock price. It will be because, through their efforts and through the extraordinary genius and humanity of Al Mann, millions and millions of diabetics throughout the world will be leading much easier lives.
* Sign at least four major marketing agreements for Afrezza. At least two will involve ultra-sensible, region-wide deals. In order of likelihood: the Mid-East, Central America and the Caribbean, and Europe. And at least three will be with specific countries. Brazil is already on board, and I suspect India is an absolutely irresistible target for Mike and company, slightly easier to ink an attractive deal than with China (key word “attractive”). I’ll bet Indonesia as a dark horse - and Canada is such an easy target too.
* Sign a major deal with BP for marketing a Technosphere vasodilator.
* Sign a medical marjiuana deal. This seems the hardest arena to predict, but I well suspect that MannKind and One Drop will ink a tri-partite deal with a major company, likely Apple or Google. So much potential there and they have the cash to make it happen quickly.
* Surprise the hell out of us with a deal no one has predicted.
So this year Mike will announce at least a half-dozen major deals. And of course MNKD will be 2018’s highest gaining NASDAQ stock, beginning today at 2.32 and ending on December 31 at 146. Up 6193%. Nice!
But I'll bet the best year-end smiles from Mike C. and the hundreds of folks who have worked so hard on Afrezza and continue to do so, won’t be about the stock price. It will be because, through their efforts and through the extraordinary genius and humanity of Al Mann, millions and millions of diabetics throughout the world will be leading much easier lives.
